arrow
S

Stephanie A. Leonard

university of california
H指数:25
被引数:3,501

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biologics and Novel Therapeutics in Food Allergy

生物制剂和新疗法在食物过敏中的应用

2026-04-070
PRE
A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design; rationale; and methods

一项使用生物制剂改善多OIT结局的2期随机对照试验(COMBINE):设计;理由;和方法

2025-12-180
OAAI
Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting

食物蛋白诱导的过敏性肠结肠炎综合征的现状与未来方向:NIAID 2022年6月22日虚拟会议工作报告

2025-02-010
PRE
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy A Randomized Clinical Trial

在牛奶过敏的儿童中,使用Viaskin牛奶与安慰剂进行不同剂量的表皮免疫治疗随机临床试验

2024-04-014
OAAI
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
2023-05-1151
PRE
Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report
2020-01-01127
PREAI
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy The PEPITES Randomized Clinical Trial
2019-03-12184
OAAI
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial

AR101在花生过敏口服免疫治疗中的疗效和安全性: ARC001的结果,一项随机,双盲,安慰剂对照的2期临床试验

2018-03-01151
OAAI
Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity A Randomized Clinical Trial
2017-11-14167
OA
International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology
2017-04-01447
OAAI